stam-1 Antibody

What is STAM-1 and what cellular functions does it participate in?

STAM-1, also known as STAM1, belongs to the STAM family of proteins. It functions primarily as an adaptor molecule in intracellular signal transduction mediated by cytokines and growth factors . STAM-1 contains a distinctive structure featuring a Src homology 3 (SH3) domain and an immunoreceptor tyrosine-based activation motif (ITAM) . Research demonstrates its involvement in signaling pathways associated with Jak2 and Jak3 tyrosine kinases, particularly in the context of interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF) signal transduction . Additionally, STAM-1 has been implicated in neuronal function, particularly in the survival of hippocampal CA3 pyramidal neurons .

What is the molecular weight of STAM-1 protein and how is this relevant for antibody detection?

STAM-1 has a calculated molecular weight of 59 kDa, though it is typically observed at approximately 70 kDa in Western blot applications . This discrepancy between calculated and observed molecular weight is significant for researchers as it indicates potential post-translational modifications such as phosphorylation or glycosylation. When validating STAM-1 antibody specificity, researchers should expect to observe bands at approximately 70 kDa rather than at the calculated 59 kDa position . This knowledge is crucial for proper interpretation of Western blot results and confirmation of antibody specificity.

In which tissues and cell types is STAM-1 expressed?

STAM-1 demonstrates ubiquitous expression across multiple tissues . Specifically, research has confirmed its presence in various cell types and tissues including:

• Neural tissue: Detected in mouse brain tissue, particularly in hippocampal neurons where it shows enrichment in synaptosomal fractions and synaptic vesicle fractions

• Immune cells: Present in Jurkat cells, K-562 cells, and Raji cells

• Cancer cell lines: Detected in HEK-293T cells, Y79 cells, MCF-7 cells, PC-3 cells, SKOV-3 cells, and HepG2 cells

• Muscle cells: Present in C2C12 cells

• Reproductive tissue: Detected in human and mouse testis tissue

Understanding this expression pattern is essential for selecting appropriate positive controls when designing experiments with STAM-1 antibodies.

What are the validated applications for STAM-1 antibody and their recommended dilutions?

STAM-1 antibody has been validated for multiple experimental applications with specific recommended dilutions as outlined in the table below:

These dilutions should be considered starting points, as optimal dilutions may need to be determined experimentally for each specific application and sample type .

What is the proper methodology for immunofluorescent staining of STAM-1 in primary neurons?

For immunofluorescent detection of STAM-1 in primary neurons, researchers should follow these methodological steps:

• Culture primary hippocampal or cortical neurons following standard protocols

• Fix cells with 4% paraformaldehyde in PBS

• Permeabilize with 0.1% Triton X-100

• Block with appropriate blocking buffer (typically 5% normal serum)

• Incubate with anti-STAM-1 antibody at dilutions between 1:50-1:500

• Follow with appropriate fluorescently labeled secondary antibody

• Consider co-staining with synaptic markers such as GluR1, Synapsin-I, or SNAP-25 to examine synaptic localization

Research has demonstrated that STAM-1 shows a distinctive spot-like staining pattern in dendrites, suggesting synaptic localization . The protein is primarily detected in the cytoplasm of dendrites and somata but not in the nuclei . When performing co-localization studies, overlapping staining between STAM-1 and synaptic markers confirms its presence in synaptic regions .

How should STAM-1 antibody be stored to maintain optimal activity?

For optimal preservation of STAM-1 antibody activity, the following storage conditions are recommended:

• Store the antibody at -20°C in aliquots to avoid repeated freeze-thaw cycles

• The antibody is typically provided in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3

• Antibody solutions are stable for one year after shipment when properly stored

• For small volume antibodies (20μl), aliquoting is unnecessary for -20°C storage

• Some preparations may contain 0.1% BSA as a stabilizer

Proper storage is crucial for maintaining antibody performance across multiple experiments and extending shelf life.

What controls should be included when validating STAM-1 antibody specificity?

Comprehensive validation of STAM-1 antibody specificity requires multiple controls:

• Positive tissue/cell controls: Include samples known to express STAM-1, such as:

  • HEK-293T cells, mouse brain tissue, Jurkat cells, or PC-3 cells for Western blot

  • Human or mouse testis tissue for immunohistochemistry

  • HepG2 cells for immunofluorescence

• Negative controls:

  • STAM-1 knockout or knockdown samples (STAM1−/− mice tissues or STAM1-silenced cells)

  • Primary antibody omission controls

  • Isotype controls using non-specific IgG

• Molecular weight verification: Confirm detection at the expected 70 kDa size in Western blot applications

• Cross-reactivity assessment: Test antibody performance across species if working with non-human models

Research has confirmed antibody specificity by demonstrating absence of staining in STAM1−/− neurons compared to wild-type neurons , providing a gold standard for validation.

How should experiments be designed to study STAM-1's role in neuronal function?

When investigating STAM-1's role in neuronal function, consider the following experimental design elements:

• Model systems:

  • Primary hippocampal or cortical neurons from wild-type and STAM1−/− mice

  • Conditional STAM-1 knockout models for temporal control

  • Overexpression and knockdown approaches in neuronal cultures

• Functional assays:

  • Excitotoxicity assays: Research indicates STAM1−/− hippocampal neurons are more vulnerable to excitotoxic amino acids and NO donors

  • Synaptic transmission measurements

  • Calcium imaging to assess neuronal activity

• Localization studies:

  • Subcellular fractionation to isolate synaptosomal and synaptic vesicle fractions

  • Co-immunoprecipitation with synaptic proteins

  • Super-resolution microscopy for precise localization at synapses

• Behavioral assessment:

  • Memory and learning tests in STAM1−/− mice to correlate with hippocampal CA3 neuron loss

This multi-faceted approach allows for comprehensive examination of STAM-1's neuronal functions from molecular to behavioral levels.

What considerations should be made when using STAM-1 antibody across different species?

When applying STAM-1 antibody across species, researchers should consider:

• Validated reactivity: Current evidence confirms reactivity with human, mouse, and rat samples

• Predicted cross-reactivity: Bioinformatic analyses suggest potential cross-reactivity with pig, zebrafish, bovine, horse, sheep, rabbit, dog, chicken, and Xenopus samples, though experimental validation is necessary

• Epitope conservation: Verify the conservation of the antibody's target epitope sequence across species of interest

• Validation strategy:

  • Begin with Western blot to confirm detection at the appropriate molecular weight

  • Use tissues with known high STAM-1 expression as positive controls

  • Include appropriate negative controls (knockout tissues when available)

  • Consider testing multiple antibodies targeting different epitopes for validation

• Dilution optimization: Optimal dilutions may vary between species and should be empirically determined

How can inconsistent Western blot results with STAM-1 antibody be addressed?

When facing inconsistent Western blot results with STAM-1 antibody, consider the following troubleshooting approaches:

• Protein extraction method:

  • STAM-1 is expressed in multiple cellular compartments, including cytoplasm and membrane-associated structures

  • Use extraction buffers containing appropriate detergents to solubilize membrane-associated proteins

  • Consider separate extraction of cytosolic and membrane fractions

• Sample preparation:

  • Include protease and phosphatase inhibitors to prevent degradation

  • Maintain consistent protein amounts (10-30 μg typically sufficient)

  • Ensure complete denaturation and reduction of samples

• Antibody dilution optimization:

  • Test multiple dilutions within the recommended range (1:2000-1:16000)

  • Consider extended incubation times at lower concentrations

• Detection system sensitivity:

  • For low abundance, use high-sensitivity chemiluminescent substrates

  • Consider using fluorescent secondary antibodies for quantitative analysis

• Expected band pattern:

  • Primary band at approximately 70 kDa despite calculated weight of 59 kDa

  • Potential additional bands may represent post-translationally modified forms

Systematic optimization of these parameters should resolve most inconsistencies in STAM-1 detection.

What strategies can address non-specific binding in immunohistochemistry experiments?

To minimize non-specific binding in STAM-1 immunohistochemistry:

• Antigen retrieval optimization:

  • For STAM-1, suggested protocols include using TE buffer pH 9.0

  • Alternative method: citrate buffer pH 6.0

  • Optimize time and temperature conditions

• Blocking optimization:

  • Use 5-10% serum from the same species as the secondary antibody

  • Consider adding 0.1-0.3% Triton X-100 for membrane permeabilization

  • Add 1% BSA to reduce non-specific protein interactions

• Antibody dilution:

  • Test dilutions in the 1:50-1:500 range

  • Increase dilution if background is excessive

• Washing protocols:

  • Extend washing times between antibody incubations

  • Include 0.05-0.1% Tween-20 in wash buffers

• Controls for specificity:

  • Include sections from STAM1−/− tissues when available

  • Perform peptide competition assays

Research has demonstrated specific STAM-1 staining in tissues like human and mouse testis with proper optimization of these parameters .

How should differential expression of STAM-1 across cellular compartments be interpreted?

Interpreting the compartmentalized expression of STAM-1 requires consideration of its multiple functional roles:

• Cytoplasmic expression:

  • Primarily observed in dendrites and neuronal somata

  • Likely represents pools involved in signal transduction pathways

  • Consider quantifying cytoplasmic intensity separately from other compartments

• Synaptic localization:

  • STAM-1 shows enrichment in synaptosomal fractions and synaptic vesicle fractions

  • Displays spot-like staining pattern in dendrites

  • Co-localizes with synaptic markers including GluR1, Synapsin-I, and SNAP-25

  • May indicate roles in vesicular transport or receptor endocytosis

• Absence from nuclei:

  • STAM-1 is not typically detected in neuronal nuclei

  • Nuclear staining should be considered non-specific

• Quantification approaches:

  • Use co-localization coefficients with compartment markers

  • Apply subcellular fractionation followed by Western blotting for quantitative assessment

  • Consider super-resolution microscopy for precise spatial localization

This compartmentalized distribution reflects STAM-1's diverse functions in signal transduction, vesicular transport, and potentially synaptic regulation.

How can STAM-1 antibody be utilized in studies of neuronal survival mechanisms?

STAM-1 antibody can be powerful tool for investigating neuronal survival mechanisms based on findings that STAM1−/− mice exhibit loss of hippocampal CA3 pyramidal neurons :

• Excitotoxicity mechanisms:

  • Use STAM-1 antibody to track protein levels and localization during excitotoxic challenge

  • Compare wild-type versus STAM1−/− primary neurons exposed to excitotoxic amino acids or NO donors

  • Quantify the relationship between STAM-1 levels and neuronal survival rates

• Signaling pathway analysis:

  • Combine STAM-1 immunoprecipitation with phosphoprotein analysis

  • Identify binding partners using co-immunoprecipitation followed by mass spectrometry

  • Map STAM-1-dependent signaling cascades in normal versus stress conditions

• Therapeutic development:

  • Screen compounds that modulate STAM-1 expression or interaction with binding partners

  • Monitor STAM-1 levels as a biomarker for neuronal vulnerability

  • Develop targeted approaches to enhance STAM-1 protective functions

• In vivo imaging:

  • Use fluorescently labeled STAM-1 antibodies for intravital imaging

  • Track STAM-1 dynamics during neurodegeneration models

This research direction is particularly relevant considering the observation that STAM1−/− neurons show increased vulnerability to excitotoxicity, suggesting STAM-1 plays a neuroprotective role .

What approaches can resolve the apparent contradiction between STAM-1's role in cytokine signaling versus neuronal function?

The research presents an interesting contradiction: while STAM-1 was initially characterized as important for IL-2 and GM-CSF signaling in vitro, STAM1−/− mice showed normal hematopoietic cell responses to these cytokines but exhibited hippocampal neuronal defects . To investigate this contradiction:

• Compensatory mechanism assessment:

  • Use STAM-1 antibody alongside antibodies for related family members (e.g., STAM2)

  • Perform quantitative analysis to detect upregulation of compensatory proteins

  • Create double or triple knockout models to overcome potential redundancy

• Cell-type specific analysis:

  • Compare STAM-1 interactome between immune cells and neurons

  • Identify tissue-specific binding partners through differential co-immunoprecipitation

  • Map subcellular localization differences between cell types

• Developmental timeline studies:

  • Track STAM-1 expression through development in different tissues

  • Analyze temporal requirements using conditional knockout models

  • Correlate expression patterns with functional outcomes

• Pathway specificity investigation:

  • Compare STAM-1 phosphorylation patterns between cytokine stimulation and neuronal activity

  • Examine different downstream effectors in immune versus neuronal contexts

This multi-faceted approach can help resolve the apparent contradictory roles of STAM-1 and potentially identify novel tissue-specific functions.

How can advanced microscopy techniques enhance STAM-1 localization studies in synaptic regions?

Given STAM-1's enrichment in synaptic regions , advanced microscopy techniques can provide deeper insights:

• Super-resolution microscopy approaches:

  • STED (Stimulated Emission Depletion) microscopy to resolve STAM-1 localization within synaptic subdomains

  • STORM (Stochastic Optical Reconstruction Microscopy) for single-molecule localization precision

  • SIM (Structured Illumination Microscopy) for improved resolution of synaptic structures

• Multi-color imaging strategies:

  • Combine STAM-1 antibody with markers for:

    • Pre-synaptic terminals (Synapsin-I, SNAP-25)

    • Post-synaptic densities (PSD-95, GluR1)

    • Endocytic zones (Clathrin, AP-2)

    • Synaptic vesicle pools (Synaptophysin)

• Live imaging approaches:

  • Utilize recombinant antibody fragments conjugated to fluorescent proteins

  • Track STAM-1 dynamics during synaptic activity

  • Correlate localization changes with electrophysiological measurements

• Expansion microscopy:

  • Apply physical expansion of samples to achieve super-resolution with standard confocal microscopy

  • Particularly useful for densely packed synaptic proteins

• Correlative light and electron microscopy (CLEM):

  • Identify STAM-1 positive synapses with fluorescence microscopy

  • Examine ultrastructural features with electron microscopy

  • Precisely map STAM-1 to synaptic subdomains

These advanced imaging approaches can provide unprecedented insights into STAM-1's precise localization and dynamic behavior at synapses, potentially revealing functional mechanisms.